What is Mixtures?
Mixtures operates as a specialized pharmacy provider, focusing on the intricate field of compounding services. The company distinguishes itself through a diverse portfolio that includes anti-aging treatments, bio-identical hormone replacement therapy, and specialized dental and veterinary preparations. By bridging the gap between standard pharmaceutical offerings and individual patient requirements, Mixtures provides essential dosage customization and professional consultations. Currently serving patients across Arizona, Colorado, and New Mexico, the firm requires licensed practitioner oversight, ensuring that its bespoke medication solutions meet rigorous clinical standards. This operational model positions the company as a critical partner for both individual patients seeking tailored health outcomes and healthcare practitioners requiring reliable, high-quality compounding support.
How much funding has Mixtures raised?
Mixtures has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Mixtures
PPP
Public-Private Partnership
What's next for Mixtures?
With the infusion of $350K, Mixtures is poised to accelerate its growth trajectory within the competitive landscape of personalized medicine. The strategic allocation of this capital will likely focus on scaling operational capacity across its existing regional hubs in the American Southwest and potentially exploring new market entries. As the demand for bio-identical hormone replacement and specialized veterinary care continues to rise, the company is expected to invest in advanced compounding technologies and regulatory compliance infrastructure. This late-stage funding phase serves as a catalyst for long-term sustainability, enabling the firm to solidify its market authority while maintaining the high-touch, patient-centric service model that defines its brand identity in the compounding pharmacy industry.
See full Mixtures company page
